Certain alkenylbenzenes (AB), flavoring chemicals naturally occurring in spices and herbs, are established to be cytotoxic and hepatocarcinogenic in rodents. The purpose of the present study was to determine the DNA damaging potential of key representatives of this class using the Turkey Egg Genotoxicity Assay. Medium white turkey eggs with 22-to 24-day-old fetuses received three injections of nine AB with different carcinogenic potentials: safrole (1, 2 mg/egg), methyl eugenol (2, 4 mg/egg), estragole (20, 40 mg/egg), myristicin (25, 50 mg/egg), elemicin (20, 50 mg/egg), anethole (5, 10 mg/egg), methyl isoeugenol (40, 80 mg/egg), eugenol (1, 2.5 mg/egg), and isoeugenol (1, 4 mg/egg). Three hours after the last injection, fetal livers were harvested for measurement of DNA strand breaks, using the comet assay and DNA adducts formation, using the nucleotide 32 P-postlabeling assay. Estragole, myristicin, and elemicin induced DNA stand breaks. These compounds as well as safrole, methyl eugenol and anethole, at the highest doses tested, induced DNA adduct formation. Methyl isoeugenol, eugenol, and isoeugenol did not induce genotoxicity. The genotoxic AB all had the structural features of either a double bond in the alkenyl side chain at the terminal 2 0 ,3 0 -position, favorable to formation of proximate carcinogenic 1 0 -hydroxymetabolite or terminal epoxide, or the absence of a free phenolic hydroxyl group crucial for formation of a nontoxic glucuronide conjugate. In contrast, methyl isoeugenol, eugenol and isoeugenol, which were nongenotoxic, possessed chemical features, unfavorable to activation.
benzene ring by a hydroxyl group can determine the carcinogenic potential of these compounds by allowing different routes of metabolism ( Figure 2 ) (Howes et al., 1990; Miller et al., 1979 Miller et al., , 1983 Rietjens et al., 2014; Smith et al., 2002) . In general, at low doses the predominant metabolic pathway for AB is O-demethylation that results in detoxification of compounds through glucuronidation ( Figure 2 ). However, at higher doses, the O-demethylation pathway becomes saturated and metabolism is shifted to 1 0 -hydroxylation and epoxidation of the allyl side chain. Such hydroxyl metabolites, predominantly in rodents, undergo sulfonation and form metabolites that readily bind to DNA, whereas the epoxidation route leads to the formation of 2 0 ,3 0 -epoxide on the allyl double bond that also is capable of DNA binding, as has been shown in vitro. In vivo epoxides, however, are more readily detoxified ( Figure 2 ) Drinkwater et al., 1976; Guenthner and Luo, 2001; Howes et al., 1990; Rietjens et al., 2005) . The data from mechanistic studies confirm that such metabolic activation of safrole, methyl eugenol, and estragole underlie their ability to induce liver neoplasia by production of DNA damage (Burkey et al., 2000; Paini et al., 2011; Phillips et al., 1984; Randerath et al., 1984; Rietjens et al., 2005; Williams et al., 2013; Wislocki et al., 1977) . Meanwhile, compounds with a free phenolic hydroxyl group, such as eugenol and isoeugenol, more readily undergo conjugation with glucuronic acid and are excreted. Thus, although still being cytotoxic to the liver, they do not share the genotoxicity of other AB (NTP, 1983 (NTP, , 2010 . Importantly, the formation of DNA adducts from exposure to AB has been observed in humans (Herrmann et al., 2013; Stening et al., 1997; Zhou et al., 2007) and even associated with carcinogenicity. For example, safrole-DNA adducts were found in oral tissues of individuals who were betel quid chewers and are thought to contribute to oral squamous cell carcinoma and esophageal cancer pathogenesis (Chen et al., 1999; Lee et al., 2005) .
To further evaluate the structure activity of AB, we have studied the in ovo DNA damage in turkey fetal livers by a set of nine compounds differing in structural features believed to be critical to carcinogenicity. The susceptibility of turkeys to environmental chemical toxins led to the discovery of a major class of potent carcinogens, the aflatoxins (Lancaster et al., 1961) . The ability of turkey livers to respond to environmental chemicals resulted in the successful use of the In Ovo Carcinogenicity Assay, a model which assesses the potential of the tested substances to produce preneoplastic lesions in turkey fetal livers (Enzmann et al., 1992 (Enzmann et al., , 2013 . The related Turkey Egg Genotoxicity Assay (TEGA) developed in this laboratory (Williams et al., 2011 ) is a novel, intact nonanimal model which uses the in ovo approach for the assessment of the potential of chemicals to induce DNA damage in the fetal turkey liver. The sensitivity of turkey fetal liver to DNA damaging activity of aflatoxin B 1 was established in this model (Williams et al., 2011) . The model is intermediate between in vitro and in vivo assays and does not require an exogenous enzyme source for bioactivation. The endpoints of the TEGA include the alkaline single cell gel electrophoresis (comet) assay which detects DNA strand breaks and the nucleotide 32 P-postlabeling (NPL) assay which detects DNA adducts. This model is similar to the Chicken Egg Genotoxicity Assay which has been successfully used for the evaluation of chemical-induced genotoxic events and proven to be a reliable tool, capable of detection of the genotoxicity of diverse DNA-reactive carcinogens, while not yielding false-positive results for noncarcinogens (Williams et al., 2014) . The detection of various DNA-reactive carcinogens that require bioactivation is possible in chicken and turkey fetal livers due to the presence of major phase I and phase II biotransformation enzymes (Hamilton et al., 1983; Perrone et al., 2004; Rifkind et al., 1979) . Moreover, the activity of the enzymes in embryonic turkey liver was shown to be similar to that in rats (Perrone et al., 2004) . The model has numerous advantages, such as: utilization of intact organisms which are terminated several days before hatching and thus are not considered to be animals; an aseptic condition with rigorous environmental control that prevents several types of bias; organisms do not possess a microbiome and hence release of endotoxin capable of enhancing the exposure effects is not a factor; provides mechanistic data that elucidates the mechanisms involved; time efficiency and lesser cost. A disadvantage of the model is a limitation on tested doses of low solubility compounds, which, however, was not a problem in the present experiments.
The present study assessed the responses of TEGA to nine structurally diverse AB in relationship to their reported genotoxicity and carcinogenicity. The results provide a basis for structure activity analysis. Figure 1 . The range of total doses is given in Table 1 .
MATERIALS AND METHODS

Chemicals
Experimental design. Fertilized broad-breasted white turkey (Meleagris gallopavo) eggs of undetermined sex were purchased from Aviagen Turkeys, Inc. (Lewisburg, West Virginia). Prior to incubation, eggs were randomly divided into control and dosed groups and stored at room temperature for no more than 3 days. The day on which incubation commenced was designated as day 0. Eggs were incubated in 2GIF Styrofoam incubator (Murray McMurray Hatchery, Webster City, Iowa) at 37 6 0.5 C and 60 6 5% humidity and manually turned 180 twice per day.
Viability was assessed on day 19 by transillumination. Eggs that did not develop were eliminated. Control and dosed (n ¼ 10 eggs per group) eggs were separated to avoid any possible airborne cross contamination. Vehicle and a dose range of each test substance: safrole, methyl eugenol, estragole, myristicin, elemicin, anethole, methyl isoeugenol, eugenol, and isoeugenol were administered in a total volume of 0.6 ml/egg through three daily injections into the air sac on days 22 through 24 of incubation. The dose ranges selected (Table 1) were based on available toxicity data (oral LD 50 in rats, which for the tested set of AB ranged from 810 to 4260 mg/kg). For each compound, the cumulative 3-day dose was expressed as mg/egg total. At termination, 3 h after the last injection, egg shells were opened, fetuses were removed and decapitated. Fetal livers were harvested; half of the collected samples were processed immediately for the comet assay, the other half was frozen at À80 C for a subsequent NPL assay. Fetal body and liver weights as well as viability were recorded. Groups chosen for analysis were required to have viability levels higher than 50% in order to avoid falsepositive results due to cytotoxicity. For each procedure, appropriate New York Medical College-Chemical Safety Laboratory Standard Operating Procedures were followed.
Alkaline single cell gel electrophoresis (comet) assay. The standard comet assay as previously reported by Tice and Strauss (1995) was performed to assess DNA strand breaks according to OECD guidelines (OECD, 2014). The protocol previously described in detail (Williams et al., 2014) was used. DNA migration was analyzed by fluorescence microscopy using a Nikon OPTIPHOT microscope. The percentage of DNA-in-tail in samples (n ¼ 3 per group) was determined using the Comet Score software v 1.5 (TriTek Corp, Sumerduck, Virginia), counting > 150 cells per sample. Median % tail DNA for each slide was determined and the mean of the median values was calculated for each fetus, group mean was calculated as an average of individual fetal means. The obtained mean comet value from each of the dose groups was then compared with the corresponding control (vehicle) group, and a ratio value which reflects the fold change from the control value was obtained. As recommended by van der Leede et al. (2014) , the evaluation criteria for determining positive results include the following: a statistically significant increase in the percentage of DNA-in-tail in dose group(s) compared with corresponding vehicle control group; a dose-related increase in DNA damage determined by linear regression analysis; the percentage of DNA-in-tail in dose group(s) should be outside of the historical vehicle control range established in the laboratory based on over 20 experiments (for 20% HS, a 95% CI is 9.73-11.68).
NPL assay. DNA adducts were assessed using the NPL method of Randerath et al. (1981) , as previously described in detail (Williams et al., 2014) . NPL analysis was conducted only for the highest tested doses of AB, as they are most likely to reveal the presence of adducts, which, according to Phillips and colleagues, is adequate for identifying a positive response (Phillips et al., 2000) .
Statistical analyses. Results are presented as mean 6 SD. Statistical analyses were performed using SigmaStat software version 3.11.0 (Systat Software Inc., Chicago, Illinois), with the most appropriate statistical analysis of the data sets, which included the one-way analysis of variance with the pairwise multiple comparison being made by Tukey's method. Linear regression analysis was used to determine dose-related trends. P values < 0.05 were considered significant.
RESULTS
The viability of turkey eggs in control groups was greater or equal to 80%, with an average value of 90%. The results are summarized in Tables 1 and 2 .
DNA strand breaks. Comet assay revealed statistically significant dose-related increase in DNA strand breaks in the livers of turkey fetuses that were dosed with 20 and 40 mg/egg of estragole (3.2-and 3.5-fold increase, respectively), whereas mortality rates were slightly increased (6% and 19% respectively), compared with the control group (Figure 3 ). Lower doses of estragole (5 and 10 mg/egg) were also tested in the comet assay, yielding positive results, ie, 1.9-and 2.5-fold increases in the percentage of tail-DNA, respectively (data not shown). The highest tested dose of myristicin (50 mg/egg) also induced a significant (1.8-fold) increase in the percentage of tail-DNA, while reducing viability by 50% (Figure 3) . Likewise, elemicin at 20 and 50 mg/ egg also yielded positive statistically significant comet results, however, not in a dose-related manner (1.65-and 1.5-fold increase, respectively). Only the highest total dose induced an increase in mortality rate by 22% (Figure 3 ). Figure 3 also shows that dosing of turkey eggs with safrole, methyl eugenol, anethole, methyl isoeugenol, eugenol, and isoeugenol had no effect on the percentage tail-DNA in comet assay. Methyl eugenol, methyl isoeugenol, and isoeugenol reduced survival of eggs (Table 1) .
DNA adducts. NPL chromatograms (Figs. 4 and 5) show that safrole, methyl eugenol, estragole, myristicin, elemicin, and anethole at the highest doses tested caused formation of DNA adducts in the livers of turkey fetuses. The highest levels of adducts were detected with 50 mg/egg of elemicin (11 025 As can be seen in the NPL chromatograms (Figure 4) , the patterns of adducts were specific for each compound.
Methyl isoeugenol, eugenol, and isoeugenol did not yield any detectable DNA adducts (Figs. 4 and 5 ) at the highest doses tested and thus were negative in the NPL assay (Table 1) .
To compare DNA-binding between positive compounds under the conditions of exposure, the total level of adducts at the highest tested dose was normalized to molecular weight (Table 2) , with the caveat that adduct formation may not be linear. Anethole showed the lowest DNA-binding activity (0.11 adducts/mM), activity of safrole was almost two times higher compared with anethole (0.25 adducts/mM), myristicin binding activity was 2.90 adducts/mM, DNA-binding levels of estragole and methyl eugenol were similar (6.99 and 8.25 adducts/mM, respectively), elemicin still was the most active, inducing formation of 45.92 adducts/mM.
DISCUSSION
The present study assessed DNA damage by nine AB using TEGA. Compounds known to be DNA-reactive carcinogens (safrole, methyl eugenol, and estragole), compounds weakly genotoxic in rodent bioassays (myristicin and elemicin) and an equivocal rodent carcinogen (anethole) yielded positive results in at least one of the assays (Tables 1 and 2 ). This indicates their ability to induce DNA strand breaks and DNA adduct formation in the turkey fetal livers. Similar DNA-binding activity for most compounds was observed in rats and mice. However, in the livers of mice, DNA binding of myristicin, elemicin, and anethole was lower compared with that in turkey fetal livers and not persistent Randerath et al., 1984) . These   FIG. 3 . The percentage of DNA-in-tail in the livers of turkey egg fetuses exposed to alkenylbenzenes. The percentage of DNA-in-tail was determined using comet assay. The results are presented as an average fold change in the percentage of tail-DNA in the turkey fetal livers from the groups dosed with AB relative to that in the corresponding control group, which was assigned a value of 1. Values are mean 6 SD (n ¼ 3). *Significant (P < .05) difference from the control group. †Significant (P < .05) trend.
findings demonstrate that turkey fetal liver can carry out the two-step bioactivation of AB, ie, epoxidation and hydroxylation followed by sulfonation. In contrast, nongenotoxic AB (methyl isoeugenol, eugenol, and isoeugenol) were negative in TEGA (Tables 1 and 2 ), demonstrating the specificity of the model response in distinguishing between genotoxic and nongenotoxic compounds with similar chemical structures.
Assays used in the current assessment, comet and NPL, are widely used highly sensitive techniques for detection of chemical-induced DNA damage (Kawaguchi et al., 2010; Phillips et al., 2000) . With regard to current recommendations, the assays were undertaken 3 h after the last injection in order to detect DNA damage at the highest exposure to the test chemical or its metabolites. Comet assay detects alkali-labile sites and sites of DNA repair (Garaj-Vrhovac and Kopjar, 2003) . Thus, compounds positive in NPL assay, estragole, myristicin and elemicin, yielded positive results in comet as well. In the case of the negative findings in comet assay for safrole, methyl eugenol and anethole, the low levels of DNA adducts formed by these compounds (Table 2) suggest that possibly there is a threshold for the comet assay detection of breaks resulting from DNA adducts, ie, comet assay does not detect low levels of DNA adducts. Thus, based on the current findings for methyl eugenol, the threshold would be 185 per 10 8 nucleotides. Another explanation can be that the DNA adducts formed after dosing with these compounds are not alkali-labile or due to the low amount are more rapidly repaired compared with those induced by estragole, myristicin, and elemicin dosing. In any event for the studied AB, the NPL assay showed higher sensitivity compared with comet assay.
AB are established to be extensively metabolized by rodents and humans Burkey et al., 2000; Gardner et al., 1997; Howes et al., 1990; Paini et al., 2011; Phillips et al., 1984; Randerath et al., 1984; Rietjens et al., 2005; Sangster et al., 1987; Stening et al., 1997; Williams and Mattia, 2009; Wislocki et al., 1977) . The carcinogenicity of safrole, methyl eugenol and estragole is largely attributed to their bioactivation by cytochrome P450 enzymes, leading to the formation of their proximate carcinogenic 1 0 -hydroxy metabolites followed by sulfonation to the ultimate carcinogenic 1 0 -sulfoxy metabolites (Figure 2 ) Borchert et al., 1973; Drinkwater et al., 1976; Gardner et al., 1997; Wislocki et al., 1977) . These unstable metabolites have carcinogenic potential due to their high DNA-binding capacity, which results in DNA adduct formation in rodents (Paini et al., 2011; Phillips et al., 1984; Randerath et al., 1984; Williams et al., 2013) . Our findings, congruent with the data obtained from rodent assays, demonstrate the genotoxic potential of safrole, methyl eugenol and estragole, as they produced increases in the levels of DNA adducts in turkey fetal livers. However, although in rodents safrole has a very strong binding ability Randerath et al., 1984) , in TEGA this compound showed relatively low DNA-binding levels. Importantly, the patterns of adducts caused by the exposure to methyl eugenol and estragole were similar to the patterns of adducts obtained from the in vivo studies of the effects of these compounds in the livers of F344 rats (Ding et al., 2015; Williams et al., 2013) . The presence of methyl eugenol DNA adducts was also detected in the livers of patients who underwent liver surgery due to various reasons, including cholangiocellular carcinoma, hepatocellular carcinoma, and liver metastases (Herrmann et al., 2013) . Moreover, dosing with estragole resulted in dose-dependent increase of DNA strand breaks (Table 1) . Similar results were observed in the studies of in vivo estragole toxicity in rodents (Ding et al., 2015) . These data suggest that DNA adduct formation and, in the case of estragole, DNA breakage may be causative factors in the hepatocarcinogenicity of these compounds. Additionally, positive outcomes for these compounds in at least one of the assays serve as a proof that turkey fetal livers are capable of performing xenobiotic metabolic activation and possess phase I enzymes that belong to cytochrome family and phase II enzymes that are crucial for sulfonation. Interestingly, previously published data provide evidence of DNA strand break induced by safrole in liver-derived cell culture systems (Bradley, 1985; Chiang et al., 2011) ; however, in vivo safrole often yielded negative comet outcomes in liver tissue (Ding et al., 2015) . Similarly, in TEGA safrole was negative in the comet assay (Table 1) . The genotoxic and carcinogenic potential of myristicin is not yet well studied. In a 12-month mouse assay conducted by Miller et al. (1983) , the compound did not show any activity for the initiation of hepatic tumors. However, myristicin showed DNA-binding activity in B6C3F1 mice and has been predicted to be weakly hepatocarcinogenic in rodent bioassay (Auerbach et al., 2010) . The findings in the current study, ie, positive results in comet and NPL (Table 1) , support the possibility of myristicin genotoxicity and carcinogenicity.
The chemical structure of elemicin possesses features that suggest potential genotoxicity. Specifically, the compound has a terminal (2 0 ,3 0 -position) double bond and does not possess a phenolic hydroxyl group for conjugation (Figure 1) . In male mice, administration of elemicin did not result in a significant increase in the formation of hepatic tumors; however, it was found to be positive in DNA-binding assays with lower potency compared with structurally related carcinogenic compounds such as estragole (Hasheminejad and Caldwell, 1994; Miller et al., 1983; Phillips et al., 1984; Randerath et al., 1984) . In TEGA, elemicin yielded positive outcomes in both comet and NPL assays, and it appeared to have the greatest genotoxic potential in turkey fetal livers among all AB tested in TEGA (Tables 1 and  2 ). Although a dose-related response in the comet assay was not observed, the increase in the percentage of DNA-in-tail was statistically significant compared with corresponding control group and the viability at the dose 50 mg/egg was decreased. We hypothesize that the slight reduction in the percentage of DNAin-tail at 50 mg/egg can be caused by decreased ability of hepatocytes to repair DNA damage due to higher toxicity of elemicin. Thus, we provide evidence of elemicin genotoxicity that should be considered in its safety evaluation, although, based on kinetic models it has been suggested that elimicin poses a lower priority for risk management (van den Berg et al., 2012) . Due to the position of the double bond in the side chain, the bioactivation of anethole leads to the formation of 3 0 -hydroxymetabolite ( Figure 2 ) that does not possess the metabolic potential of the proximate carcinogenic 1 0 -hydroxymetabolite and more readily undergoes detoxification and elimination in the urine (Caldwell and Sutton, 1988; Sangster et al., 1987) . The epoxidation of the side chain, the major metabolic route for anethole, was believed to lead to cytotoxicity but not genotoxicity (Marshall and Caldwell, 1991) . Previously, anethole was not considered to be genotoxic (Gorelick, 1995; Howes et al., 1990) . However, in our study anethole induced formation of DNA adducts, showing that it has genotoxic potential (Table 1) , although when compared with other compounds tested, its DNA-binding activity was the lowest ( Table 2 ). Importantly, anethole has been shown to produce low levels of DNA adducts in newborn and adult mice Randerath et al., 1984) and to cause a very small increase in the incidences of hepatocellular carcinoma in female rats (Newberne et al., 1999; Truhaut et al., 1989) . The synthetic metabolite trans-anethole oxide (or anethole epoxide) was mutagenic in bacteria and increased the incidences of hepatomas in male B6C3F1 mice and skin papillomas in female CD-1 mice (Kim et al., 1999) . Investigation of the metabolism of beta-asarone, a known rodent hepatocarcinogenic AB with a similar chemical structure to anethole, revealed that epoxidation of the side chain double bond was the major metabolic route for the compound, resulting in the formation of unstable and highly reactive epoxides which are ultimate carcinogens (Cartus et al., 2015) . These data in combination with the findings from the current study suggest that epoxidation of anethole might lead to the formation of reactive genotoxic metabolites. Methyl isoeugenol also possesses the double bond at the 1 0 ,2 0 -position. Despite a lack of definitive evidence, methyl isoeugenol is claimed to be nongenotoxic (Hasheminejad and Caldwell, 1994) and is approved by U.S. Food and Drug Administration for human consumption (USFDA, 2010). The administration of the compound in diet to Sprague Dawley male and female rats at up to 300 mg/kg body weight/day did not induce any adverse effects (Purchase et al., 1992) . The data from the published studies that investigated the metabolism of methyl isoeugenol show that its major metabolite was a nongenotoxic 3 0 -hydroxy metabolite (Cartus et al., 2011) , whereas epoxidation of the side chain plays a minor role (Solheim and Scheline, 1976) . These peculiarities of methyl isoeugenol metabolism caused by chemical structure can explain the difference in genotoxic potential of methyl isoeugenol and structurally similar methyl eugenol, the latter showed neoplasm-initiating activity in the livers of male F344 rats as a result of DNA-binding (Williams et al., 2013) . The findings in TEGA support the hypothesis for the lack of the genotoxicity of methyl isoeugenol (Table  1) . When comparing these findings with the results of anethole testing in TEGA, it can be concluded that despite the position of alkenyl double bond in anethole, it is capable of forming reactive metabolites, possibly due to more active epoxidation, a metabolic route which does not prevail in methyl isoeugenol biotransformation. Eugenol and isoeugenol both possess a free phenolic hydroxyl group which is readily conjugated with glucuronic acid or sulfate to form stable metabolites which are excreted in the urine (Fischer et al., 1990) . In rodents, 2-year carcinogenicity studies of eugenol showed no significant increase in the incidences of malignant liver tumors and equivocal evidence of carcinogenic activity of isoeugenol in male rats and mice (NTP, 1983 (NTP, , 2010 . It is possible that weak carcinogenicity of isoeugenol can be caused by other mechanisms, eg, oxidative DNA damage. In rodents, eugenol and isoeugenol did not yield any detectable DNA adducts Randerath et al., 1984) . Similarly, in TEGA both compounds did not induce DNA damage, thus, strengthening the evidence for their lack of genotoxicity (Table 1) .
In summary, our findings congruently with the data obtained from previous studies confirm in a newly tested species the genotoxic potential of safrole, methyl eugenol, and estragole, supporting the interpretation that their toxicity is caused by chemical specific DNA damage. Interestingly, myristicin, elemicin, and anethole also yielded positive results in at least one of the assays providing evidence of their genotoxicity. Lack of genotoxicity of methyl isoeugenol, eugenol, and isoeugenol supports the hypothesis that the genotoxicity of AB is determined by their chemical structure, specifically, 1 0 ,2 0 -position of the double bond in the side chain which is not favorable to formation of proximate carcinogenic 1 0 -hydroxymetabolite or terminal epoxide, or the presence of a free phenolic hydroxyl group, which leads to the formation of a nontoxic glucuronide conjugate. These findings in TEGA extend the range of compounds demonstrated to elicit genotoxicity (Perrone et al., 2004; Williams et al., 2011) .
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